Thus, in a moderate blood loss the blockade of AT1 receptors with losartan reduces AVP secretion, but in severe blood loss other additional mechanisms probably sustain AVP-secretion in response to hemorrhage after the blockade of AT1 signaling. Here, AGTR1 is linked to hemorrhage.